ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 680

$954K Total Retail Price of All Prescriptions

Rank: 90 out of 680

333 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

22% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,448 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 484 369 1 6
SIMVASTATIN 398 260 2 3
LEVOTHYROXINE SODIUM 351 255 3 2
METOPROLOL TARTRATE 282 205 4 12
NAMENDA 274 244 5 35
AMLODIPINE BESYLATE 271 202 6 1
NEXIUM 270 180 7 16
HYDROCODONE-ACETAMINOPHEN 257 224 S3 8 4
RANITIDINE HCL 251 204 9 56
DONEPEZIL HCL 229 217 10 27
SERTRALINE HCL 229 174 10 28
LISINOPRIL 218 125 12 5
KLOR-CON M20 215 193 13 61
LACTULOSE 213 120 14 92
RISPERIDONE 201 117 15 80
MEGESTROL ACETATE 189 155 R 16 88
NOVOLIN R 180 114 17 113
POTASSIUM CHLORIDE 176 83 18 14
CLOPIDOGREL 173 106 19 26
OMEPRAZOLE 160 131 20 7
TAMSULOSIN HCL 158 83 21 34
NIASPAN 145 98 22 181
WARFARIN SODIUM 142 120 23 20
AZELASTINE HCL 142 121 23 240
JANTOVEN 141 130 25 147
PLAVIX 140 80 26 39
OXYBUTYNIN CHLORIDE 138 109 27 129
METFORMIN HCL 137 92 28 8
TRAZODONE HCL 136 96 29 48
ENALAPRIL MALEATE 134 71 30 65
GABAPENTIN 131 72 31 15
DIGOXIN 130 100 32 58
MUPIROCIN 128 82 33 130
LANTUS 125 62 34 49
FLUTICASONE PROPIONATE 119 90 35 41
BACLOFEN 119 86 35 140
HYDROCHLOROTHIAZIDE 117 80 37 9
IPRATROPIUM BROMIDE 117 62 37 211
ESCITALOPRAM OXALATE 116 57 39 45
IBUPROFEN 115 87 40 126
METOPROLOL SUCCINATE 112 72 41 13
DIOVAN 111 52 42 31
LEVETIRACETAM 109 62 43 120
QUETIAPINE FUMARATE 109 83 43 64
GLYBURIDE 108 66 R 45 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 73 46 94
DIVALPROEX SODIUM 100 60 47 110
POLYETHYLENE GLYCOL 3350 99 49 48 62
BENZTROPINE MESYLATE 94 12 R 49 137
ZOLPIDEM TARTRATE 93 55 50 17
METOCLOPRAMIDE HCL 93 38 50 118
CYMBALTA 87 59 52 46
NYSTATIN 86 70 53 191
HUMULIN R 86 43 53 195
EXELON 86 70 53 112
DOXEPIN HCL 84 34 56 200
PRAVASTATIN SODIUM 84 62 56 10
CLOZAPINE 84 0 56 286
CITALOPRAM HBR 83 69 59 22
ABILIFY 83 47 59 178
PANTOPRAZOLE SODIUM 82 55 61 30
ATORVASTATIN CALCIUM 81 62 62 11
GLIPIZIDE 80 45 63 63
CARVEDILOL 78 60 64 23
VENLAFAXINE HCL ER 76 63 65 101
FAMOTIDINE 75 59 66 89
ALENDRONATE SODIUM 73 53 67 32
MIRTAZAPINE 73 57 67 78
FLUOXETINE HCL 72 47 69 74
NITROFURANTOIN MONO-MACRO 71 52 70 172
LIDODERM 71 53 70 221
LABETALOL HCL 70 26 72 158
ALLOPURINOL 68 60 73 33
DIVALPROEX SODIUM ER 66 31 74 148
SANTYL 64 54 75 170
NOVOLOG 63 43 76 167
LATANOPROST 62 49 77 209
CLONIDINE HCL 62 45 77 36
CLOTRIMAZOLE-BETAMETHASONE 62 31 77 138
PAROXETINE HCL 58 41 80 76
CARBIDOPA-LEVODOPA 57 24 81 117
SEROQUEL 57 43 81 123
VALPROIC ACID 56 11 83 254
FENOFIBRATE 56 43 83 66
HYDRALAZINE HCL 56 24 83 71
BENAZEPRIL HCL 54 35 86 40
NYSTOP 53 35 87 305
ADVAIR DISKUS 53 45 87 53
OLANZAPINE 53 44 87 116
NITROGLYCERIN PATCH 51 37 90 271
PHENYTOIN SODIUM EXTENDED 51 29 90 115
ALBUTEROL SULFATE 50 23 92 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.